SEC Extends EGC Rule, Modernizes ETF Rules

September 26, 2019 | Latest News, News, Regulations
https://dailyalts.com/wp-content/uploads/2019/09/Flag_of_the_United_States_Securities_and_Exchange_Commission.svg_-845x321.png

New Rules Extend “Test the Waters” Rule, Increases ETF Innovation

The SEC announced Wednesday it had adopted new rules that extend the “test-the-waters” accommodation. Previously, the tool was only available to “emerging growth companies” or “EGCs.” Now, all issuers may take part. The accommodation is part of several actions by the SEC to expand the JOBS Act provisions and allow firms to obtain capital on U.S. markets. It will go into effect in 6daysay after the publication in the Federal Registrar.

The new rule allows issuers to test market interest in registered securities like IPS with certain institutional investors. They may do so before or after they file a registration statement.

“The final rule benefits from the staff’s experience with the test-the-waters accommodation that has been available to EGCs since the Jumpstart Our Business Startups Act (JOBS Act),” SEC Chairman Jay Clayton said in a statement.  “Investors and companies alike will benefit from test-the-waters communications, including increasing the likelihood of successful public securities offerings.”

The new rule is one of several SEC initiatives. The agency wants to build on the JOBS Act provisions that encourage companies to access our public markets.

SEC Expands ETF Rules

On the same day, the SEC also adopted a new rule to modernize ETF regulations. The agency has adopted “a clear and consistent framework for the vast majority of ETFs operating today,” it said.

The SEC expects that the new rules will promote greater innovation and competition in the ETF industry.

“Since ETFs were first developed over 27 years ago, they have provided investors with several benefits, including access to a wide array of investment strategies, in many cases at a low cost,” said Clayton. “As the ETF industry continues to grow in size and importance, particularly to Main Street investors, it is important to have a consistent, transparent, and efficient regulatory framework that eliminates regulatory hurdles while maintaining appropriate investor protections.”

Finally, the rules will expedite the time-to-market for ETF products and improve relief practices.

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Shape

Latest Alternative Investment News

https://dailyalts.com/wp-content/uploads/2023/05/webimage-5e3ef5d0-aee9-4a3e-9d3e-c26109b53529.png
FinTech: Klarna’s All-In Efforts To Achieve Profitability Getting Traction
May 26, 2023     FinTech, News

Swedish fintech company Klarna achieved a significant improvement in its financial performance during the first quarter, as it halved its net loss compared to the same period last year. The…

https://dailyalts.com/wp-content/uploads/2023/05/ai-generated-g831120c83_640.jpg
Alternative Investments/AI: Euclidean Technologies Launches ETF For AI-Selected Value Stocks

Seattle-based investment advisor Euclidean Technologies Management has launched its first exchange-traded fund (ETF), the Euclidean Fundamental Value ETF (ECML US). The actively managed US equity fund utilizes artificial intelligence (AI)…

https://dailyalts.com/wp-content/uploads/2023/05/aditya-siva-6rDbvXzIVpQ-unsplash.jpg
Venture Capital: Matrix Partners Raises $550M For Its Fourth India Fund
May 26, 2023     News, Venture Capital

Matrix Partners India, a venture capital firm focused on investments in India, has announced the closure of its latest fund, securing over $550 million in commitments. This new fund from…

https://dailyalts.com/wp-content/uploads/2023/05/52747633301_b52ecbc442_c.jpg
Artificial Intelligence: AI Helps Researchers Find A Compound To Kill The Drug-Resistant A. baumannii Bacterium

Scientists at MIT and McMaster University have used artificial intelligence (AI) to identify a new antibiotic that can combat drug-resistant infections caused by Acinetobacter baumannii. The bacterium is commonly found…